USA Paralympics sitting volleyball player Jillian Williams, who beat Ewing sarcoma with help from San Antonio and Houston medical teams, is going for the gold in the Tokyo Paralympics.

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.

The Mays Cancer Center, home to UT Health San Antonio MD Anderson, was named a founding partner of the Advancing Inclusive Research® Site Alliance.

The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.

Physicians with the Mays Cancer Center, home to UT Health San Antonio MD Anderson, praised the May 18 move by the U.S. Preventive Services Task Force to lower from 50 to 45 the recommended age to begin screening asymptomatic persons to prevent colorectal cancer. The goal is to identify and remove precancerous benign polyps. Physicians nationwide adhere to the panel’s guidelines.

This first-of-its-kind national cohort study will unpack the social, cultural, behavioral, psychosocial, biological and medical influences on post-cancer life in Latino cancer survivors to fill a crucial gap in knowledge about their survivorship experience.

According to the study, 53.4% of participants receiving NF were free of cancer at three months and 45.5% of patients continued to be cancer-free for at least 12 months.

Individuals with cancer who get COVID-19 are more likely to have severe illness and higher death rates compared to the general public. This study aims to help prevent worse outcomes in patients with cancer and COVID-19

Bladder cancer is more aggressive and more advanced in South Texas residents ­than in many parts of the country, a study by the Mays Cancer Center indicates.

UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.